References
- M Sparago, J Wlos, J Yuan, G Hatzidimitriou, J Tolliver, TA Dal Cason, J Katz, G Ricaurte. 1996. Neurotoxic and pharmacologic studies on enantiomers of the N-Methylated analog of cathinone (methcathinone): A new drug of abuse. J Pharmacol Exp Ther 279 (2):1043–1052.
- NV Cozzi, KF Foley. 2003. Methcathinone is a substrate for the serotonin uptake transporter. Pharmacol Toxicol 93 (5):219–225.
- OS Levin. 2005. Ephedron encephalopathy. Zh Nevrol Psikhiatr Im S S Korsakova 105 (7):12–20.
- Y Sanotsky, R Lesyk, L Fedoryshyn, I Komnatska, Y Matviyenko, S Fahn. 2007. Manganic encephalopathy due to “ephedrone” abuse. Mov Disord 22 (9):1337–1343.
- MP Gygi, WG James, GR Hanson. 1996. Methcathinone: An initial study of its effects on monoaminergic systems. JPET 276:1066–1072.
- UD McCann, DF Wong, F Yokoi, V Villemagne, RF Dannals, GA Ricaurte. 1998. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: Evidence from positron emission tomography studies with (11C) WIN–35,428. J Neurosci 18 (20):8417–8422.
- K Sikk, P Taba, S Haldre, J Bergquist, D Nyholm, G Zjablov, T Asser, SM Aquilonius. 2007. Irreversible motor impairment in young addicts-ephedrone, manganism or both?. Acta Neurol Scand 115 (6):385–389.
- RM de Bie, RM Gladstone, AP Strafella, JH Ko, AE Lang. 2007. Manganese induced parkinsonism associated with methcathinone (ephedrone) abuse. Arch Neurol 64 (6):886–889.
- H Meral, Y Kutukcu, B Atmaca, F Ozer, K Hamamcioglu. 2007. Parkinsonism caused by chronic usage of intravenous potassium permanganate. The Neurologist 13:92–94.
- M Aschner, KM Ericson, DC Dorman. 2005. Manganese dosimetry: Species differences and implications for neurotoxicity. Crit Rev Toxicol 35 (1):1–32.
- PK Pal, A Sami, DB Calne. 1999. Manganese neurotoxicity: A review of clinical features, imaging and pathology. NeuroToxicology 20 (2–3):227–238.
- J Crossgrove, W Zheng. 2004. Manganese toxicity upon overexposure. NMR Biomed 17:544–553.
- MG Cersosimo, WC Koller. 2006. The diagnosis of manganese induced parkinsonism. NeuroToxicology 27:340–346.
- W Zheng, H Kim, Q Zhao. 2000. Comparative toxicokinetics of manganese chloride and methylcyclopentadienyl manganese tricarbonyl (MMT) in Sprague-Dawley rats. Toxicol Sci 54:295–301.
- G Discalzi, E Pira, EH Hernandez, C Valentini, M Turbiglio, F Meliga. 2000. Occupational Mn parkinsonism: magnetic resonance imaging and clinical patterns following CaNa2-EDTA Chelation. NeuroToxicology 21 (5):863–866.
- YM Jiang, XA Mo, FQ Du, X Fu, XY Zhu, HY Gao, JL Xie, FL Liao, E Pira, W Zheng. 2006. Effective treatment of manganese-induced occupational Parkinsonism with p-aminosalicylic acid: a case of 17-year follow-up study. J Occup Environ Med 48 (6):644–9.
- CA Haller, NL Benowitz. 2000. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Eng J Med 343:1833–1838.
- JF Bowyer, GD Newport, W SlikkerJr, B Gough, SA Fergusson, J Tor-Agbidye. 2000. An evaluation of l-ephedrine neurotoxicity with respect to hyperthermia and caudate/putamen microdialysate levels of ephedrine, dopamine, serotonin, and glutamate. Toxicol Sci. 55 (1):133–142.
- AC Munhall, SW Johnson. 2006. Dopamine mediated actions of ephedrine in the rat substantia nigra. Brain Res 1069 (1):96–103.